Thursday, November 19, 2026
  • Home
  • About us
  • Privacy policy
  • Advertise with us
  • Contact us
Fii News Logo
No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
  • ASEANFastest Growing
Newsletter
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
  • ASEANFastest Growing
Fiinews
No Result
View All Result
Home Economy

Propanc granted trademark in India

Fiinews by Fiinews
December 21, 2018
in Economy, Health, Imports, Investment
Reading Time: 2 mins read
A A
0
0
SHARES
45
VIEWS
LinkedinShare on Twitter

PwC sees US$50bn Indian market

 

Source: Propanc Biopharma Inc.

 

Melbourne’s Propanc Biopharma, Inc. said its foundation patent application has been granted by the Office of the Controller General of Patents, Design and Trademarks in India, a market of US$50 billion by 2020.

The foundation patent, which covers the Company’s lead product candidate, PRP, pioneers the discovery of a pharmaceutical composition for treating cancer via a combination of trypsinogen and/or chymotrypsinogen pancreatic proenzymes.

Propanc cited a report by PwC looking at prospects for growth, which predicts that the Indian Pharmaceutical market will reach US$50 Billion and become one of the sector’s top 10 markets in the world by 2020.

“Building a robust patent portfolio has been a top priority in driving our drug development technology forward. Adding India to the growing list of countries where we have been granted patents reflects the strength of our growing IP portfolio for PRP,” said James Nathanielsz, Propanc’s Chief Executive Officer.

“Historically, patent prosecution in this region is challenging, especially in the biopharmaceutical sector, but we believe the smooth process reflects the quality of our claims and the strength of our technology.

“We are very excited to have this key global region under patent protection and have only two jurisdictions remaining to attain global patent protection in all countries selected for prosecution,” said Nathanielsz.

So far, the foundation patent has been granted in the USA, Europe (including Belgium, Czech Republic, Denmark, France, Germany, Ireland, Italy, the Netherlands, Portugal, Spain, Sweden, Switzerland/Liechtenstein, Turkey and the United Kingdom), China, Japan, Indonesia, Malaysia, Israel, Australia, New Zealand, Singapore, South Africa, Mexico, Republic of Korea, Hong Kong and more recently, India.

It is presently under examination in Canada and Brazil.

Propanc Biopharma is a biopharmaceutical company developing new cancer treatments initially for patients suffering from pancreatic, ovarian and colorectal cancers. fiinews.com

Tags: Inc.Propanc Biopharma
ShareTweetShare

Related Posts

HZL and Vedanta combined logo
Investment

Invest: HZL to double production to 2 mtpa

by Fiinews
November 19, 2026
0
15

CEO Prakash works on HZL 2.0 for India’s industrial development. Hindustan Zinc Limited (HZL - NSE:HINDZINC), the world’s largest integrated...

Singapore Exchange
Investment

Invest: UTI Nifty listed in Singapore

by Fiinews
November 14, 2026
0
20

India’s 50 most liquid NSE-listed companies can be traded in SGD-USD SGX Stock Exchange said the UTI India Nifty 50...

A7

Invest: A7 expands cross-border payment in India

November 12, 2026
25
Andersen

Invest: Andersen makes acquisitions in India

November 12, 2026
20
Bharat Mobility

Invest: Japanese keen in partnering with Indians

November 12, 2026
20
Foxconn in Hungary

Invest: Businesses urged to explore opportunities

November 8, 2026
29
SBI YONO

Recent News

  • Project: MoD inks contract with Israel Aerospace Industries
  • Market: Urban consumers prefer electric mobility
  • Invest: HZL to double production to 2 mtpa
  • Market: Rootstock expands in India through Conserve
  • Market: HGS-Rackspace to grow in high-value GCCs

Pages

  • About US
  • ADVERTISE ON FIINEWS.COM
  • CONTACT US
  • EVENTS
  • FII-NEWS.COM PDF ARCHIVE
  • Home
  • News
  • PRIVACY POLICY
  • About
  • Advertise
  • Careers
  • Contact us

© 2026 FIINEWS - Design and developed by 7clicksmedia.

No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
  • ASEAN

© 2026 FIINEWS - Design and developed by 7clicksmedia.